Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-22-004426
Filing Date
2022-01-07
Accepted
2022-01-07 16:01:32
Documents
12
Period of Report
2021-12-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K/A d286779d8ka.htm   iXBRL 8-K/A 23278
  Complete submission text file 0001193125-22-004426.txt   149912

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cris-20211202.xsd EX-101.SCH 2515
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cris-20211202_lab.xml EX-101.LAB 18767
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cris-20211202_pre.xml EX-101.PRE 11765
6 EXTRACTED XBRL INSTANCE DOCUMENT d286779d8ka_htm.xml XML 4644
Mailing Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421 617-503-6500
CURIS INC (Filer) CIK: 0001108205 (see all company filings)

IRS No.: 043505116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-30347 | Film No.: 22518143
SIC: 2836 Biological Products, (No Diagnostic Substances)